Therefore, understanding how IL-6 trans-signaling elicits a cellular pro-arrhythmic phenotype and its use as an anti-arrhythmic target in a model of obesity remain unmet clinical needs. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.